[1]李 莲.丁苯酞注射液联合阿托伐他汀钙对急性脑梗死患者脑血流变及神经功能的影响[J].医学信息,2022,35(20):63-66.[doi:10.3969/j.issn.1006-1959.2022.20.015]
　LI Lian.Effect of Butylphthalide Injection Combined with Atorvastatin Calcium on Cerebral Hemorheology and Neurological Function in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2022,35(20):63-66.[doi:10.3969/j.issn.1006-1959.2022.20.015]
点击复制

丁苯酞注射液联合阿托伐他汀钙对急性脑梗死患者脑血流变及神经功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年20期
页码:
63-66
栏目:
论著
出版日期:
2022-10-15

文章信息/Info

Title:
Effect of Butylphthalide Injection Combined with Atorvastatin Calcium on Cerebral Hemorheology and Neurological Function in Patients with Acute Cerebral Infarction
文章编号:
1006-1959（2022）20-0063-04
作者:
李 莲
（奉新县人民医院神经内科，江西 奉新 330700）
Author(s):
LI Lian
(Department of Neurology,Fengxin County People’s Hospital,Fengxin 330700,Jiangxi,China)
关键词:
急性脑梗死; 丁苯酞注射液; 阿托伐他汀钙; 脑血流变; 神经功能
Keywords:
Acute cerebral infarction; Butylphthalide injection; Atorvastatin calcium; Cerebral blood rheology; Nerve function
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.20.015
文献标志码:
A
摘要:
目的 观察急性脑梗死患者联合应用丁苯酞注射液与阿托伐他汀钙治疗对脑血流变及神经功能的影响。方法 选择2020年1月-12月奉新县人民医院神经内科收治的急性脑梗死患者60例，根据随机数字表法分为治疗组和对照组，各30例。对照组给予阿托伐他汀钙治疗，治疗组在对照组基础上联合丁苯酞注射液治疗。比较两组收缩期峰值流速（PSV）、搏动指数（PI）、舒张期末血流速度（EDV）、格拉斯哥昏迷指数（GCS评分）、同型半胱氨酸（HCY）、颅外椎动脉（VA）、颈内动脉（ICA）的血液平均流速（Vm）、血流变异减速（Vd）、血流最低流速（Vs）。结果 治疗7 d后，治疗组PSV、EDV高于对照组（P＜0.05），而两组VA、ICA的PI比较，差异无统计学意义（P＞0.05）；治疗组GCS评分高于对照组，HCY水平低于对照组（P＜0.05）；治疗组VA、ICA的Vs、Vd、Vm高于对照组（P＜0.05）。结论 急性脑梗死患者联合应用丁苯酞注射液与阿托伐他汀钙治疗可降低颅内压，减轻神经功能及氧自由基损伤，改善脑血流变，提高脑功能，临床应用效果良好。
Abstract:
Objective To observe the effect of butylphthalide injection combined with atorvastatin calcium on cerebral hemorheology and neurological function in patients with acute cerebral infarction.Methods Sixty patients with acute cerebral infarction admitted to the Department of Neurology, Fengxin County People’s Hospital from January to December 2020 were selected and divided into a treatment group and a control group according to the random number table method, with 30 cases in each group. The control group was treated with atorvastatin calcium, and the treatment group was treated with butylphthalide injection on the basis of the control group. The peak systolic velocity (PSV), pulsatility index (PI), end diastolic velocity (EDV), Glasgow coma score (GCS), homocysteine (HCY), mean blood flow velocity (Vm), deceleration of blood flow variability (Vd) and minimum blood flow velocity (Vs) of extracranial vertebral artery (VA) and internal carotid artery (ICA) were compared between the two groups.Results After 7 days of treatment, PSV and EDV in the treatment group were higher than those in the control group (P<0.05), but there was no significant difference in PI of VA and ICA between the two groups (P>0.05). The GCS score of the treatment group was higher than that of the control group, and the HCY level was lower than that of the control group (P<0.05). The Vs, Vd and Vm of VA and ICA in the treatment group were higher than those in the control group (P<0.05).Conclusion The combination of butylphthalide injection and atorvastatin calcium in patients with acute cerebral infarction can reduce intracranial pressure, reduce neurological function and oxygen free radical damage, improve cerebral blood flow and improve brain function, and the clinical application effect is good.

参考文献/References:

[1]中华医学会神经外科学分会,国家卫健委脑卒中筛查与防治工程委员会,海峡两岸医药卫生交流协会神经外科分会缺血性脑血管病学组.大面积脑梗死外科治疗指南[J].中华医学杂志,2021,101(45):3700-3711.[2]邹蔷薇,王惠婕,何欣,等.局部亚低温联合丁苯酞注射液治疗对急性脑梗死患者细胞凋亡及斑块稳定性的影响[J].疑难病杂志,2019,18(11):1099-1102,1107.[3]李霜梅,蔡娟,石小晶,等.丁苯酞软胶囊联合阿托伐他汀钙片对脑梗死病人侧支循环建立的影响[J].中西医结合心脑血管病杂志,2017,15(1):103-105.[4]张剑,刘芳怡,陈源,等.丁苯酞序贯联合常规用药治疗脑梗死合并颈内动脉中重度狭窄患者的临床研究[J].中国临床药理学杂志,2021,37(14):1851-1854.[5]牛亚妹,刘丽.阿加曲班联合丁苯酞治疗急性脑梗死临床评价[J].中国药业,2020,29(20):86-88.[6]蒙医康复临床实践指南·脑梗死制定工作组,乌兰图雅,辛浩,等.蒙医康复临床实践指南·脑梗死[J].康复学报,2021,31(4):271-278.[7]Lin B,Wang C,Lu N,et al.Reversible cerebral vasoconstriction syndrome with cerebral infarction caused by acute high-level vapor exposure of ethylene oxide: a case report[J].BMC Neurol,2021,21(1):391.[8]宋祺,孙西庆.红花黄色素注射液联合丁苯酞氯化钠注射液治疗急性脑梗死的效果观察[J].山东医药,2021,61(13):72-75.[9]叶佳媚,林青,彭飞飞.丁苯酞注射液联合双重抗血小板对急性进展性脑梗死的疗效及其机制探讨[J].中国现代医学杂志,2021,31(9):60-66.[10]杨蓉,李寅珍,严首春.丁苯酞氯化钠注射液联合rt-PA超时间窗溶栓治疗急性脑梗死患者的效果评价[J].中国中西医结合急救杂志,2021,28(3):316-319.[11]刘迪 ,朱秋红,郭宏伟,等.丁苯酞氯化钠注射液治疗超静脉溶栓时间窗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2021,24(6):511-515.[12]Wang H,Lu H,Zhang XM,et al.Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction[J].BMC Neurol,2021,21(1):274.[13]马红彦,刘翠青,李桂德,等.丁苯酞注射液联合阿替普酶静脉溶栓治疗急性脑梗死疗效及对IGF-1、CRP、BNP水平的影响[J].现代中西医结合杂志,2021,30(25):2796-2799.[14]石小晶,李秀敏,杨文军,等.丁苯酞注射液联合银杏二萜内酯注射液对急性脑梗死患者的疗效及侧支循环的改善作用[J].河北医药,2021,43(19):2965-2968.[15]Wang W,Wang S,Zhang K,et al.Hypothyroidism is associated with clinical outcomes in patients with acute myocardial infarction: subgroup analysis of China PEACE study[J].Endocrine,2021,74(1):128-137.[16]Suzuki ARCSY,Tsubakino S,Fujii H.Motor Function and Activities of Daily Living Recovery after Cardiogenic Internal Carotid Artery Infarction:A Retrospective Cohort study[J].J Stroke Cerebrovasc Dis,2021,30(6):105734.[17]陈萍.脑心通胶囊联合丁苯酞注射液治疗急性脑梗死的疗效观察及对血清炎性因子、氧化应激反应、血液流变学的影响[J].中国基层医药,2021,28(10):1516-1520.[18]Liu M,Pu Y,Gu J,et al.Evaluation of Zhilong Huoxue Tongyu capsule in the treatment of acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials[J].Phytomedicine,2021,86:153566.[19]王琴,孔伟丽,吕康,等.氯吡格雷联合丁苯酞注射液治疗急性脑梗死的效果及对抗氧化能力的影响[J].临床误诊误治,2021,34(4):39-43.[20]余芬.丁苯酞注射液联合丹红注射液治疗急性脑梗死60例[J].中国新药杂志,2018,27(24):2901-2904.[21]汪传香,丁砚兵.丁苯酞氯化钠注射液治疗急性缺血性脑梗死的疗效观察[J].现代药物与临床,2017,32(9):1655-1659.[22]唐娟娟,余朝萍.丁苯酞注射液联合对症治疗对OCSP分型急性脑梗死患者血清IMA、LP-PLA2水平的影响[J].中国急救复苏与灾害医学杂志,2021,16(5):509-512.[23]张东风.丁苯酞联合阿托伐他汀对急性脑梗死患者血流动力学及血清SOD、GSH-Px、NO水平的影响[J].临床药物治疗杂志,2018,16(3):37-41.[24]姜永宁.丁苯酞联合阿托伐他汀治疗对急性脑梗死患者血清SOD、GSH-Px、NO水平的影响[J].内科急危重症杂志,2018,24(3):206-209.

相似文献/References:

[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(20):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Journal of Medical Information,2022,35(20):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[3]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(20):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[4]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Journal of Medical Information,2018,31(20):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[5]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2022,35(20):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[6]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(20):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[7]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[8]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[9]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Journal of Medical Information,2019,32(20):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[10]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Journal of Medical Information,2019,32(20):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]

更新日期/Last Update: 1900-01-01